| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
trans-golgi network protein 2 | 2.8E-03 |
|
group | 0.310 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||||
|
immunoglobulin lambda variable 3-25 | 1.000 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
calcium/calmodulin dependent protein kinase II inhibitor 2 | 1.000 | 0.077 | 0.22 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Major affective disorder 4 | 0.780 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
Major affective disorder 6 | 0.780 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
zinc finger protein 34 | 0.931 | 0.115 | 6.9E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
Temple syndrome | 0.780 | 0.154 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
group | 0.310 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 1 | 2001 | 2004 | |||||||||
|
immunoglobulin superfamily member 9B | 0.821 | 0.192 | 0.87 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1F | 0.716 | 0.192 | 4.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
translin associated factor X | 0.760 | 0.192 | 0.49 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
regulator of G protein signaling 8 | 0.821 | 0.192 | 0.30 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
group | 0.330 | None | 0.333 | 3 | 1 | 2000 | 2010 | ||||||||
|
trace amine associated receptor 6 | 0.780 | 0.231 | 1.7E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 3 | 0.769 | 0.231 | 1.5E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
agmatinase | 0.839 | 0.231 | 1.2E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
major affective disorder 1 | 0.743 | 0.269 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 0.617 | 0.269 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
phosphofructokinase, liver type | 0.722 | 0.269 | 2.7E-17 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
thrombospondin 3 | 0.792 | 0.269 | 2.6E-21 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
WASH complex subunit 1 | 0.780 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
Major depressive disorder | 0.682 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
hes family bHLH transcription factor 6 | 0.686 | 0.308 | 8.4E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 |